These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 27056896)

  • 1. Dyrk1a regulates the cardiomyocyte cell cycle via D-cyclin-dependent Rb/E2f-signalling.
    Hille S; Dierck F; Kühl C; Sosna J; Adam-Klages S; Adam D; Lüllmann-Rauch R; Frey N; Kuhn C
    Cardiovasc Res; 2016 Jun; 110(3):381-94. PubMed ID: 27056896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced expression of DYRK1A in cardiomyocytes inhibits acute NFAT activation but does not prevent hypertrophy in vivo.
    Grebe C; Klingebiel TM; Grau SP; Toischer K; Didié M; Jacobshagen C; Dullin C; Hasenfuss G; Seidler T
    Cardiovasc Res; 2011 Jun; 90(3):521-8. PubMed ID: 21273244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
    Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
    J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DYRK1A is a novel negative regulator of cardiomyocyte hypertrophy.
    Kuhn C; Frank D; Will R; Jaschinski C; Frauen R; Katus HA; Frey N
    J Biol Chem; 2009 Jun; 284(25):17320-17327. PubMed ID: 19372220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of pRb by cyclin D kinase is necessary for development of cardiac hypertrophy.
    Hinrichsen R; Hansen AH; Haunsø S; Busk PK
    Cell Prolif; 2008 Oct; 41(5):813-29. PubMed ID: 18700867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the dual-specificity tyrosine phosphorylation-regulated kinase 1A-alternative splicing factor-calcium/calmodulin-dependent protein kinase IIδ signaling pathway in myocardial infarction-induced heart failure of rats.
    He J; Yao J; Sheng H; Zhu J
    J Card Fail; 2015 Sep; 21(9):751-60. PubMed ID: 26067684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DYRK1A controls the transition from proliferation to quiescence during lymphoid development by destabilizing Cyclin D3.
    Thompson BJ; Bhansali R; Diebold L; Cook DE; Stolzenburg L; Casagrande AS; Besson T; Leblond B; Désiré L; Malinge S; Crispino JD
    J Exp Med; 2015 Jun; 212(6):953-70. PubMed ID: 26008897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.
    Streicher JM; Ren S; Herschman H; Wang Y
    Circ Res; 2010 Apr; 106(8):1434-43. PubMed ID: 20339119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversible regulation of the retinoblastoma protein/E2F-1 pathway during "reverse cardiac remodelling" after ventricular unloading.
    Wohlschlaeger J; Schmitz KJ; Takeda A; Takeda N; Vahlhaus C; Stypmann J; Schmid C; Baba HA
    J Heart Lung Transplant; 2010 Jan; 29(1):117-24. PubMed ID: 20123249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay between the E2F pathway and β-adrenergic signaling in the pathological hypertrophic response of myocardium.
    Major JL; Salih M; Tuana BS
    J Mol Cell Cardiol; 2015 Jul; 84():179-90. PubMed ID: 25944088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocysteinemia-induced Dyrk1a downregulation results in cardiomyocyte hypertrophy in rats.
    Raaf L; Noll C; Cherifi M; Benazzoug Y; Delabar JM; Janel N
    Int J Cardiol; 2010 Nov; 145(2):306-307. PubMed ID: 19906449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
    Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J
    Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct roles of GSK-3alpha and GSK-3beta phosphorylation in the heart under pressure overload.
    Matsuda T; Zhai P; Maejima Y; Hong C; Gao S; Tian B; Goto K; Takagi H; Tamamori-Adachi M; Kitajima S; Sadoshima J
    Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20900-5. PubMed ID: 19106302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Down syndrome-related protein kinase DYRK1A phosphorylates p27(Kip1) and Cyclin D1 and induces cell cycle exit and neuronal differentiation.
    Soppa U; Schumacher J; Florencio Ortiz V; Pasqualon T; Tejedor FJ; Becker W
    Cell Cycle; 2014; 13(13):2084-100. PubMed ID: 24806449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-199b targets the nuclear kinase Dyrk1a in an auto-amplification loop promoting calcineurin/NFAT signalling.
    da Costa Martins PA; Salic K; Gladka MM; Armand AS; Leptidis S; el Azzouzi H; Hansen A; Coenen-de Roo CJ; Bierhuizen MF; van der Nagel R; van Kuik J; de Weger R; de Bruin A; Condorelli G; Arbones ML; Eschenhagen T; De Windt LJ
    Nat Cell Biol; 2010 Dec; 12(12):1220-7. PubMed ID: 21102440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: a metabolic contribution to heart failure with normal ejection fraction.
    Mori J; Basu R; McLean BA; Das SK; Zhang L; Patel VB; Wagg CS; Kassiri Z; Lopaschuk GD; Oudit GY
    Circ Heart Fail; 2012 Jul; 5(4):493-503. PubMed ID: 22705769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy.
    Huang S; Zou X; Zhu JN; Fu YH; Lin QX; Liang YY; Deng CY; Kuang SJ; Zhang MZ; Liao YL; Zheng XL; Yu XY; Shan ZX
    J Cell Mol Med; 2015 Mar; 19(3):608-19. PubMed ID: 25583328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FasL expression in cardiomyocytes activates the ERK1/2 pathway, leading to dilated cardiomyopathy and advanced heart failure.
    Huby AC; Turdi S; James J; Towbin JA; Purevjav E
    Clin Sci (Lond); 2016 Feb; 130(4):289-99. PubMed ID: 26566650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic mouse in vivo library of human Down syndrome critical region 1: association between DYRK1A overexpression, brain development abnormalities, and cell cycle protein alteration.
    Branchi I; Bichler Z; Minghetti L; Delabar JM; Malchiodi-Albedi F; Gonzalez MC; Chettouh Z; Nicolini A; Chabert C; Smith DJ; Rubin EM; Migliore-Samour D; Alleva E
    J Neuropathol Exp Neurol; 2004 May; 63(5):429-40. PubMed ID: 15198122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and activity of the retinoblastoma protein (pRB)-family proteins, p107 and p130, during L6 myoblast differentiation.
    Kiess M; Gill RM; Hamel PA
    Cell Growth Differ; 1995 Oct; 6(10):1287-98. PubMed ID: 8845306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.